The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-cyanobenzoic acid ID: ALA4565065
PubChem CID: 139207789
Max Phase: Preclinical
Molecular Formula: C22H16N6O4
Molecular Weight: 428.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(C(=O)O)c(NC(=O)c2ccc(Cc3c[nH]c4nc(N)[nH]c(=O)c34)cc2)c1
Standard InChI: InChI=1S/C22H16N6O4/c23-9-12-3-6-15(21(31)32)16(8-12)26-19(29)13-4-1-11(2-5-13)7-14-10-25-18-17(14)20(30)28-22(24)27-18/h1-6,8,10H,7H2,(H,26,29)(H,31,32)(H4,24,25,27,28,30)
Standard InChI Key: MEWIMDIPLNOYGN-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
27.6566 -4.6431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6566 -5.4603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3618 -5.8648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3618 -4.2304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0671 -4.6431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0716 -5.4568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8468 -5.7040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.3215 -5.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8396 -4.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3618 -3.4132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9494 -5.8699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0878 -3.6089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8862 -3.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4329 -4.0424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2306 -3.8686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4796 -3.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9246 -2.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1290 -2.6606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2777 -2.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8287 -3.5175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.5249 -2.1351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3231 -1.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8696 -2.5641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6671 -2.3892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9150 -1.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3593 -1.0047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5639 -1.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0093 -0.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2524 0.2063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2121 -0.7617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2141 -2.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7647 -3.5982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
2 11 1 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
28 29 1 0
28 30 2 0
27 28 1 0
31 32 3 0
24 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 428.41Molecular Weight (Monoisotopic): 428.1233AlogP: 2.25#Rotatable Bonds: 5Polar Surface Area: 177.75Molecular Species: ACIDHBA: 6HBD: 5#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.43CX Basic pKa: 1.96CX LogP: 2.84CX LogD: -0.38Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.32Np Likeness Score: -0.86
References 1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS.. (2019) Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors., 183 [PMID:31536894 ] [10.1016/j.ejmech.2019.111673 ]